These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 11079587

  • 1. Papillary thyroid carcinoma associated with parathyroid adenoma detected by pertechnetate-MIBI subtraction scintigraphy.
    Rubello D, Toniato A, Pelizzo MR, Casara D.
    Clin Nucl Med; 2000 Nov; 25(11):898-900. PubMed ID: 11079587
    [Abstract] [Full Text] [Related]

  • 2. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
    Rubello D, Saladini G, Casara D, Borsato N, Toniato A, Piotto A, Bernante P, Pelizzo MR.
    Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
    [Abstract] [Full Text] [Related]

  • 3. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Lind P.
    Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
    [Abstract] [Full Text] [Related]

  • 4. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.
    Casara D, Rubello D, Pelizzo MR, Shapiro B.
    Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294
    [Abstract] [Full Text] [Related]

  • 5. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
    Powell DK, Nwoke F, Goldfarb RC, Ongseng F.
    Clin Imaging; 2013 Sep; 37(3):475-9. PubMed ID: 23102932
    [Abstract] [Full Text] [Related]

  • 6. [Use of SPECT with (99m)Tc-Sestamibi in a patient affected by laryngeal carcinoma and parathyroid adenoma].
    Giordano A, Galli J, Corina L, Samanes Gajate AM, D'Andrea G, Almadori G.
    Rev Esp Med Nucl; 2000 Jun; 19(3):211-4. PubMed ID: 11062085
    [Abstract] [Full Text] [Related]

  • 7. Autonomous thyroid adenoma, papillary thyroid carcinoma, and ectopic parathyroid adenoma in a patient with primary hyperparathyroidism and a nontoxic multinodular goiter.
    Kirkwood ID, Chatterton BE, Malycha P, Guha S.
    Clin Nucl Med; 1997 Jul; 22(7):491-3. PubMed ID: 9227878
    [No Abstract] [Full Text] [Related]

  • 8. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the differential diagnosis of cold thyroid nodules.
    Mezosi E, Bajnok L, Gyory F, Varga J, Sztojka I, Szabo J, Galuska L, Leovey A, Kakuk G, Nagy E.
    Eur J Nucl Med; 1999 Aug; 26(8):798-803. PubMed ID: 10436190
    [Abstract] [Full Text] [Related]

  • 9. [High retention of (99m)Tc-MIBI in delayed phase as a pitfall in the combined parathyroid-thyroid scintigraphy].
    Verdú J, Lizárraga C, Clavel J, Prata I, Calbo J, Pomares F.
    Rev Esp Med Nucl; 2010 Aug; 29(5):251-3. PubMed ID: 20381207
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Determinant role of Tc-99m MIBI SPECT in the localization of a retrotracheal parathyroid adenoma successfully treated by radioguided surgery.
    Rubello D, Casara D, Pagetta C, Piotto A, Pelizzo MR, Shapiro B.
    Clin Nucl Med; 2002 Oct; 27(10):711-5. PubMed ID: 12352113
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid dual tracer subtraction scintigraphy: small regions method for quantitative assessment of parathyroid adenoma uptake.
    Koljević Marković A, Janković MM, Marković I, Pupić G, Džodić R, Delaloye AB.
    Ann Nucl Med; 2014 Oct; 28(8):736-45. PubMed ID: 24947176
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 'Shine through' on dual tracer parathyroid scintigraphy: a potential pitfall in interpretation.
    Liu Y, Chun KJ, Freeman LM.
    Clin Nucl Med; 2005 Mar; 30(3):145-9. PubMed ID: 15722816
    [Abstract] [Full Text] [Related]

  • 18. Concomitant hyperparathyroidism and nonmedullary thyroid cancer, with a review of the literature.
    Leitha T, Staudenherz A.
    Clin Nucl Med; 2003 Feb; 28(2):113-7. PubMed ID: 12544127
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 99mTc-SestaMIBI scintigraphy of thyroid gland in a patient with primary hyperparathyroidism: unusual features due to coesistence of a thyroid papillary carcinoma.
    Boi F, Cau R, Piga M, Serra A, Loy M, Lai ML, Mariotti S.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):823-4. PubMed ID: 14974929
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.